此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Home Treatment of Acute Pancreatitis

2013年2月21日 更新者:Ali Tüzün İnce、Bezmialem Vakif University

A Randomized Controlled Trial of Home Monitoring Versus Hospitalization in Mild Non-Alcoholic Acute Interstitial Pancreatitis

Acute pancreatitis (AP) is considered a disease requiring in-hospital treatment. We studied the feasibility of home management in AP.The aim of study was to compare 30 day readmission rates in patients with mild non-alcoholic acute pancreatitis (NAAP) randomized to home monitoring versus hospitalization.

研究概览

地位

完全的

详细说明

Between 11/11-5/12, 84 patients with mild NAAP were randomized to home or hospital groups after a short (≤24 hours) hospital stay. AP was defined as ≥2 or more of the following: characteristic abdominal pain, amylase and/or lipase ≥3X the upper limit of normal, and/or imaging findings. Patients with an Imrie's score ≤5 and a harmless acute pancreatitis score (HAPS) ≤2 were included. Patients in both groups received intravenous lactated Ringer for 3 days and pain was treated with intramuscular diclofenac. A nurse visited all patients in the home group on the 2nd, 3rd and 5th day. All patients recalled for follow-up on the 7th, 14th, and 30th days.

研究类型

观察性的

注册 (实际的)

84

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • İstanbul、火鸡、34093
        • Bezmialem Vakıf University Hospital, Gastroenterology Clinic

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

概率样本

研究人群

Mild acute non-alhololic patients managed in home.

描述

Inclusion Criteria:

  • Diagnosis of AP based on 2 out of 3 findings: characteristic abdominal pain, amylase and/or lipase levels ≥3 times the upper limit of normal, and/or abdominal imaging demonstrating changes of acute pancreatitis
  • Presentation within 48 hours of symptom onset
  • Imrie's scores of ≤5 and HAP score ≤2 within 24 hours of presentation to the hospital
  • Lack of hemoconcentration (hematocrit ≥44%) on presentation since hemoconcentration has been shown to be a risk factor for pancreatic necrosis.

Exclusion Criteria:

  • The presence of organ failure by the Atlanta criteria on the first day of presentation
  • The presence of clinical signs and/or symptoms of sepsis
  • Alcoholic acute pancreatitis
  • A history of abdominal imaging demonstrating a dilated pancreatic duct and/or pancreatic calcifications
  • Coagulopathy (international normalized ratio >1, and/or platelet count <50,000/mm3
  • Comorbidities requiring hospitalization regardless of the presence of AP e.g. acute myocardial infarction, malignancy, cirrhosis, chronic kidney disease, and chronic pulmonary disease)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:队列
  • 时间观点:预期

队列和干预

团体/队列
Home and hospital treatment groups
Patients were randomized into either home or hospital groups after a brief hospitalization(≤24 hours. Hospital patients were followed 5 days in hospital.Home patients were visited on 2nd,3rd and 5th days by a staff nurse and the vital signs, symptoms, and general condition were recorded and transmitted back to the attending physician. On the 7th, 14th and 30th days, the home and hospital group patients were requested to return for a follow-up clinic visit at Bezmialem, at which time an assessment of their symptoms, physical examination, and laboratory evaluation was conducted.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The primary outcome of the study was the 30 day hospital readmission rate.
大体时间:30 days
30 day hospital readmission of home and hospital groups of patients were evaluated.
30 days

次要结果测量

结果测量
措施说明
大体时间
Other outcomes evaluated included the duration of abdominal pain and time to resumption of an oral diet, both measured in hours from the time of presentation.
大体时间:hours

Elaboration time of abdominal pain in home and hospital group patients as hour from the admission time to ICU.

Time to resumption of an oral diet measured from the time of presentation.

hours

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Hakan Şentürk, Prof.、Bezmialem Vakıf University Hospital, Gastroenterology Clinic

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2011年11月1日

初级完成 (实际的)

2012年6月1日

研究完成 (实际的)

2012年6月1日

研究注册日期

首次提交

2013年2月19日

首先提交符合 QC 标准的

2013年2月21日

首次发布 (估计)

2013年2月22日

研究记录更新

最后更新发布 (估计)

2013年2月22日

上次提交的符合 QC 标准的更新

2013年2月21日

最后验证

2013年2月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • B.30.2.BAV.0.05.05/374

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅